||Garg, A., Chapel, S. et al (2010, June). A Mechanism Based Population Pharmacokinetic-Pharmacodynamic Model for Epoetin Alfa and Darbepoetin Alfa in Chronic Kidney Disease Patients. Poster session presented at the annual meeting of the Population Approach Group in Europe, Berlin, Germany.
Chapel, S. et al (2009, October). Semi-mechanistic Model for Characterizing the Effect of Rifampin Co-administration on the Pharmacokinetics of Efavirenz. Poster session presented at the annual meeting of the American Conference on Pharmacometrics, Mashantucket, CT.